Blog

The Lead Broker model is broken. Here is the fix
January 27, 2026 by Susan Mohr Stop buying “Mystery Dockets” Is your current lead vendor providing you with a verifiable chain of custody for every plaintiff? If the answer is “no,” your docket is vulnerable. At Mohr Marketing, we have ended the era of the “Lead Broker.” We are currently using proprietary AI Website Tracking technology to help firms acquire cases… Continue reading The Lead Broker model is broken. Here is the fix
New Agency Model (Post-pay media + Compliance)
January 26, 2026 by Susan Mohr I know “compliance” isn’t usually the most exciting topic, but given the recent crackdowns on lead generation, we wanted to ensure our partners are insulated from risk before ramping up MVA volume for 2026. To ensure long-term stability and quality, we are transitioning to a Subscription-Based Agency Model in 2026. This new structure is designed… Continue reading New Agency Model (Post-pay media + Compliance)
The Mohr Marketing Compliance Shield
January 26, 2026 by Susan Mohr Avoiding the “File and Extort” trap in personal injury cases A Multi-Layered Vetting & Verification Protocol For decades, we have delivered tens of thousands of retained cases by adhering to a simple principle: Compliance is not optional. We continuously refine our technology stack to ensure every lead is verified, authentic, and retention-ready. ✅ Phase 1:… Continue reading The Mohr Marketing Compliance Shield
Avoiding Fraud in Mass Torts
January 25, 2026 by Susan Mohr “Cheap” Leads Ruining Your Docket? Avoiding Fraud in Mass Torts Looking to increase capacity in active MDLs? This video details how Mohr Marketing delivers high-quality, fully screened, retention-ready MDL intake without the risk of fraud. We specialize in navigating the surge of Mass Tort litigation by utilizing SEC-level security standards. We ensure your firm avoids… Continue reading Avoiding Fraud in Mass Torts
Navigating the MDL Surge: Why Compliance Defines Case Quality
January 24, 2026 by Susan Mohr With Multidistrict Litigation (MDL) dockets expanding rapidly—including over 67k+ cases for J&J Talc alone—law firms face a critical challenge: How do you scale volume without polluting your docket with fraudulent claims? In this video, we explore the high cost of “cheap” leads and why Mohr Marketing has adopted a compliance-first approach to Mass Tort intake.… Continue reading Navigating the MDL Surge: Why Compliance Defines Case Quality
Why Smart Firms Are Switching to AI-Powered Marketing Support
January 23, 2026 by Susan Mohr The “Signed Case” is Dead: Why Smart Firms Are Switching to AI-Powered Marketing Support Legal Marketing / Ethics & Compliance For years, the “Holy Grail” of personal injury marketing was the “Signed Case”—a neat little package where a vendor did everything, including signing the retainer, and handed it to the attorney. But in 2026, that… Continue reading Why Smart Firms Are Switching to AI-Powered Marketing Support
MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
January 22, 2026 by Susan Mohr Allocation Strategy: Bard (MDL 2846) vs. Covidien (MDL 3029) EXECUTIVE SUMMARY The “Hernia Mesh” bucket is no longer a single asset class. As we enter Q1 2026, the litigation has bifurcated into two distinct phases. Bard has transitioned into a mature “Administration & Cleanup” phase, where value is found only in specific, high-damage claims. Covidien,… Continue reading MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
Solving the “Fake Lead” Crisis in Mass Torts with AI
January 22, 2026 by Susan Mohr The end of the “Lead Broker” model in MDLs With MDL judges increasingly scrutinizing plaintiff inventories and defense counsel flagging “bot” submissions in high-profile torts, the integrity of legal lead generation is facing a crisis. I am writing to share how Mohr Marketing is addressing this head-on. We have moved away from the traditional “Lead… Continue reading Solving the “Fake Lead” Crisis in Mass Torts with AI
The Bard Hernia Mesh Landscape in 2026
January 21, 2026 by Susan Mohr Bard Settlement vs. Covidien Growth: Where to Put Your Budget in 2026 For the last five years, MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc.) has been a cornerstone of many mass tort inventories. However, following Becton Dickinson’s October 2024 announcement of a global settlement framework (approx. $1.9 billion reserved for ~38,000 claims), the strategy… Continue reading The Bard Hernia Mesh Landscape in 2026
The “Hernia Mesh” bucket is no longer a single asset class
January 21, 2026 by Susan Mohr Mohr Marketing Launches “Post-Settlement” Protocol for Bard Mesh; Opens New Acquisition Channels for Emerging Covidien Litigation Dual-strategy for 2026: Strict “Tier 1” filtration for mature Bard dockets and aggressive growth focus for Covidien (MDL 3029). Mohr Marketing, a specialized digital agency for the legal sector, today announced a strategic overhaul of its hernia mesh acquisition… Continue reading The “Hernia Mesh” bucket is no longer a single asset class
Secret Link